Connection

Gregory Sempowski to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Gregory Sempowski has written about Antibodies, Viral.
Gregory Sempowski
Connection Strength
0.086
Antibodies, Viral
  1. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
    View in: PubMed
    Score: 0.021
  2. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19. Cell. 2020 06 25; 181(7):1458-1463.
    View in: PubMed
    Score: 0.021
  3. Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires. Immunity. 2018 01 16; 48(1):174-184.e9.
    View in: PubMed
    Score: 0.018
  4. Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test. Sci Adv. 2021 06; 7(26).
    View in: PubMed
    Score: 0.006
  5. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 08 05; 184(16):4203-4219.e32.
    View in: PubMed
    Score: 0.006
  6. Cold sensitivity of the SARS-CoV-2 spike ectodomain. Nat Struct Mol Biol. 2021 02; 28(2):128-131.
    View in: PubMed
    Score: 0.005
  7. Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort. Vaccine. 2018 10 29; 36(45):6650-6659.
    View in: PubMed
    Score: 0.005
  8. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017 03 09; 543(7644):248-251.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.